Press Release: Uromedica : First Patients Enrolled in Uromedica's Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence (SUI) Trial

MINNEAPOLIS--(BUSINESS WIRE)-- Uromedica, Inc. announces the initiation of its FDA Investigational Device Exemption trial for ACT® to evaluate its safety and efficacy for treatment of female SUI. Stress urinary incontinence is the...